Cargando…
Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis
INTRODUCTION: A retrospective study was conducted on patients at Penn State Hershey Medical Center diagnosed with relapsing–remitting multiple sclerosis between 2006 and 2015. METHODOLOGY: Laboratory and clinical data collected over this 10-year period were reviewed. Two cohorts of patients were est...
Autores principales: | Ludwig, Michael D, Turel, Anthony P, Zagon, Ian S, McLaughlin, Patricia J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433405/ https://www.ncbi.nlm.nih.gov/pubmed/28607740 http://dx.doi.org/10.1177/2055217316672242 |
Ejemplares similares
-
Low-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic
por: McLaughlin, Patricia J., et al.
Publicado: (2022) -
Naltrexone as a Novel Therapeutic for Diabetic Corneal Complications
por: McLaughlin, Patricia J., et al.
Publicado: (2020) -
Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes
por: McLaughlin, Patricia J., et al.
Publicado: (2019) -
Low-Dose Naltrexone for Pruritus in Systemic Sclerosis
por: Frech, Tracy, et al.
Publicado: (2011) -
Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study
por: Raknes, Guttorm, et al.
Publicado: (2017)